다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of the American Academy of Dermatology, v.43 no.6, 2000년, pp.991 - 1000
Henrique, Rui (Porto, Portugal) , Azevedo, Rosa (Porto, Portugal) , Bento, Maria José (Porto, Portugal) , Domingues, José (Porto, Portugal) , Carlos (Porto, Portugal) , Silva, Cristina (Porto, Portugal) , Jerónimo, Carmen
AI-Helper
AbstractBackground: The proliferative activity of some tumors is related to the development of metastatic disease and survival. Thus it could be used as a potential prognostic variable. Objective: The purpose of this study was to determine the prognostic value of the Ki-67 index and of a “pro...
CA Cancer J Clin Rigel 46 195 1996 10.3322/canjclin.46.4.195 Malignant melanoma: perspectives on incidence and its effects on awareness, diagnosis and treatment
CA Cancer J Clin Parker 47 5 1997 10.3322/canjclin.47.1.5 Cancer statistics, 1997
Ann Surg Balch 188 732 1978 10.1097/00000658-197812000-00004 A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's methods
Ann Surg Day 195 35 1982 10.1097/00000658-198201001-00006 Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51-3.99 mm)
J Cutan Pathol McGovern 9 61 1982 10.1111/j.1600-0560.1982.tb01044.x The nature of melanoma: a critical review
Cancer Karakousis 64 1432 1989 10.1002/1097-0142(19891001)64:7<1432::AID-CNCR2820640712>3.0.CO;2-M Tumor thickness and prognosis in clinical stage I malignant melanoma
Ann Surg Breslow 172 902 1970 10.1097/00000658-197011000-00017 Thickness, cross-sectional area, and depth of invasion in the prognosis of cutaneous melanoma
Br J Cancer Haffner 66 856 1992 10.1038/bjc.1992.373 The prognosis of primary and metastasising melanoma: an evaluation of the TNM classification in 2,495 patients
World J Surg Soong 16 191 1992 10.1007/BF02071520 Predicting survival and recurrence in localized melanoma: a multivariate approach
Cancer Buttner 75 2499 1995 10.1002/1097-0142(19950515)75:10<2499::AID-CNCR2820751016>3.0.CO;2-8 Primary cutaneous melanoma: optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification
Cancer Res Hedley 47 4729 1985 Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer
J Pathol Hall 154 223 1988 10.1002/path.1711540305 The prognostic value of Ki67 immunostaining in non-Hodgkins lymphoma
Radiother Oncol Tubiana 15 1 1989 10.1016/0167-8140(89)90113-8 Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival
Haematol Oncol Gerdes 2 365 1984 10.1002/hon.2900020406 Growth fractions in malignant non-Hodgkin's lymphomas as determined in situ with the monoclonal antibody Ki-67
Br J Haematol Pileri 65 271 1987 10.1111/j.1365-2141.1987.tb06853.x Immunohistochemical determination of growth fractions in human permanent cell lines and lymphoid tumors: a critical comparison of the monoclonal antibodies OKT9 and Ki-67
Exp Cell Res Wersto 179 79 1988 10.1016/0014-4827(88)90350-3 Cell cycle-dependent reactivity with the monoclonal antibody Ki 67 during myeloid cell proliferation
Anal Cell Pathol Guillaud 1 25 1989 Quantification and topographical description of Ki-67 antibody labelling during the cell cycle of normal fibroblastic (MRC-5) and mammary tumour cell lines (MCF-7)
Pathol Res Pract Smolle 187 986 1991 10.1016/S0344-0338(11)81070-8 Computer simulation analysis of morphological patterns in human melanocytic skin tumors
Cancer Costa 60 2797 1987 10.1002/1097-0142(19871201)60:11<2797::AID-CNCR2820601133>3.0.CO;2-B Cell kinetics as a prognostic tool in patients with metastatic malignant melanoma of the skin
J Invest Dermatol Moretti 95 320 1990 10.1111/1523-1747.ep12485060 Ki67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions
J Cutan Pathol Soyer 18 264 1991 10.1111/j.1600-0560.1991.tb01234.x Ki 67 immunostaining in melanocytic skin tumours: correlation with histologic parameters
J Pathol Evans 168 15 1992 10.1002/path.1711680104 Mitotic indices, anti-PCNA immunostaining and AgNORs in thick cutaneous melanomas displaying paradoxical behaviour
J Invest Dermatol Ramsey 105 22 1995 10.1111/1523-1747.ep12312431 MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous malignant melanoma
J Am Acad Dermatol Boni 35 416 1996 10.1016/S0190-9622(96)90607-6 MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma
Histopathology Vogt 30 57 1997 10.1046/j.1365-2559.1996.d01-558.x p53 protein and Ki-67 expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin
Melanoma Res Hernberg 8 283 1998 10.1097/00008390-199806000-00013 Prognostic value of biomarkers in malignant melanoma
J Cutan Pathol Smolle 19 110 1992 10.1111/j.1600-0560.1992.tb01351.x Prognostic significance of proliferation and motility in primary malignant melanoma of the skin
J Cutan Pathol Rieger 20 229 1993 10.1111/j.1600-0560.1993.tb00648.x Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions: a quantitative immunohistochemical study
J Cutan Pathol Reddy 22 248 1995 10.1111/j.1600-0560.1995.tb00746.x Cell proliferation markers in predicting metastases in malignant melanoma
Cancer Res Clark 29 705 1969 The histogenesis and biologic behavior of primary human malignant melanomas of the skin
Arch Dermatol Schmoeckel 114 871 1978 10.1001/archderm.1978.01640180005001 Prognostic index in malignant melanoma
American Joint Committee on Cancer 163 1997 Malignant melanoma of the skin
Cancer Kopf 59 1236 1987 10.1002/1097-0142(19870315)59:6<1236::AID-CNCR2820590634>3.0.CO;2-I Prognostic index for malignant melanoma
J Natl Cancer Inst Clark 81 1893 1989 10.1093/jnci/81.24.1893 Model predicting survival in stage I melanoma based on tumour progression
Int J Cancer Worth 43 370 1989 10.1002/ijc.2910430303 Pathologic prognostic factors for cutaneous malignant melanoma: the Western Canada Melanoma Study
Ann Surg Kheir 207 455 1988 10.1097/00000658-198804000-00014 Prognostic significance of DNA aneuploidy in Stage I cutaneous melanoma
Hum Pathol Donhuijsen 17 1122 1986 10.1016/S0046-8177(86)80417-8 Mitosis counts: reproducibility and significance in grading of malignancy
J Clin Pathol Cross 43 597 1990 10.1136/jcp.43.7.597 Does delay in fixation affect the number of mitotic figures in processed tissue?
J Pathol Quinn 160 93 1990 10.1002/path.1711600202 The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables
Soong 200 1992 A computerized mathematical model and scoring system for predicting outcome in melanoma patients
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.